LRIG3 Antikörper (AA 835-985)

Produktnummer ABIN7158211

Produktdetails anti-LRIG3 Antikörper

Target: LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))

Bindungsspezifität: AA 835-985

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LRIG3 Antikörper ist unkonjugiert

Applikation: ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Leucine-rich repeats and immunoglobulin-like domains protein 3 protein (835-985AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu LRIG3

Target: LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))

Andere Bezeichnung: LRIG3 (LRIG3 Produkte)

Synonyme: LRIG3 antikoerper, lrig3 antikoerper, GB17149 antikoerper, LIG3 antikoerper, 9030421L11Rik antikoerper, 9130004I02Rik antikoerper, 9430095K15Rik antikoerper, mKIAA3016 antikoerper, RGD1561255 antikoerper, leucine rich repeats and immunoglobulin like domains 3 antikoerper, leucine-rich repeats and immunoglobulin-like domains 3 antikoerper, leucine-rich repeats and immunoglobulin-like domains protein 3 antikoerper, leucine-rich repeats and immunoglobulin like domains 3 S homeolog antikoerper, leucine-rich repeats and immunoglobulin like domains 3 antikoerper, LRIG3 antikoerper, lrig3 antikoerper, LOC726128 antikoerper, lrig3.S antikoerper, Lrig3 antikoerper

Hintergrund:

Background: May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity).

Aliases: Leucine-rich repeats and immunoglobulin-like domains protein 3 antibody, Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3 antibody, LIG-3 antibody, LIG3 antibody, LRIG1-3 antibody, Lrig3 antibody, LRIG3_HUMAN antibody

UniProt: Q6UXM1